Oncologix Tech, Inc.
OCLG
$0.0001
$0.000.00%
OTC PK
| 05/31/2015 | |||||
|---|---|---|---|---|---|
| Net Income | 0.00% | ||||
| Total Depreciation and Amortization | 6.38% | ||||
| Total Amortization of Deferred Charges | 45.81% | ||||
| Total Other Non-Cash Items | 1.46% | ||||
| Change in Net Operating Assets | 84.92% | ||||
| Cash from Operations | 83.17% | ||||
| Capital Expenditure | -200.00% | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -- | ||||
| Cash from Investing | -200.00% | ||||
| Total Debt Issued | -0.99% | ||||
| Total Debt Repaid | 1.62% | ||||
| Issuance of Common Stock | -- | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | 1.35% | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | 289.05% | ||||